{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:00:31Z","timestamp":1777611631497,"version":"3.51.4"},"reference-count":87,"publisher":"Elsevier","isbn-type":[{"value":"9780128136690","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-12-813669-0.00010-5","type":"book-chapter","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T09:50:40Z","timestamp":1520416240000},"page":"437-466","source":"Crossref","is-referenced-by-count":7,"title":["Mesoporous silica nanoparticles as drug delivery systems against melanoma"],"prefix":"10.1016","author":[{"given":"A.","family":"Zieli\u0144ska","sequence":"first","affiliation":[]},{"given":"I.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"S.","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"F.J.","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"A.C.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"I.","family":"Nowak","sequence":"additional","affiliation":[]},{"given":"A.M.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"E.B.","family":"Souto","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijpharm.2011.05.079","article-title":"Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability","volume":"416","author":"Alhnan","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.colsurfb.2014.10.047","article-title":"Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies","volume":"123","author":"Andreani","year":"2014","journal-title":"Coll. Surf. B: Biointer."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10973-014-4275-4","article-title":"Effect of cryoprotectants on the reconstitution of silica nanoparticles produced by sol-gel technology","volume":"120","author":"Andreani","year":"2014","journal-title":"J. Thermal Anal. Calor."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejpb.2015.03.027","article-title":"Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: interactions with mucin and biomembrane models","volume":"93","author":"Andreani","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/B978-0-12-813669-0.00010-5_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/bab.1322","article-title":"Silica-based matrices: state of the art and new perspectives for therapeutic drug delivery","volume":"62","author":"Andreani","year":"2015","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib6","first-page":"16","article-title":"Drug delivery from structured porous inorganic materials","volume":"4","author":"Arruebo","year":"2012","journal-title":"Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol."},{"issue":"7","key":"10.1016\/B978-0-12-813669-0.00010-5_bib7","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","article-title":"High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993","volume":"17","author":"Atkins","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/B978-0-12-813669-0.00010-5_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1039\/C6BM00039H","article-title":"Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution","volume":"4","author":"Baeza","year":"2016","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/B978-0-12-813669-0.00010-5_bib9","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1172\/JCI45600","article-title":"Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma","volume":"121","author":"Benezra","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/B978-0-12-813669-0.00010-5_bib10","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/17425247.2011.618181","article-title":"Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water soluble drugs","volume":"8","author":"Bikiaris","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425247.2016.1211637","article-title":"Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer","volume":"14","author":"Castillo","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib12","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/IJN.S45429","article-title":"Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics","volume":"8","author":"Chen","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/B978-0-12-813669-0.00010-5_bib13","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1021\/acs.molpharmaceut.6b00352","article-title":"Enhanced sensitivity of cancer stem cells to chemotherapy using functionalized mesoporous silica nanoparticles","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/B978-0-12-813669-0.00010-5_bib14","first-page":"1","article-title":"Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients","volume":"10","author":"Daud","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/B978-0-12-813669-0.00010-5_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib16","doi-asserted-by":"crossref","first-page":"1600408","DOI":"10.1002\/biot.201600408","article-title":"Controlled release and intracellular protein delivery from mesoporous silica nanoparticles","volume":"12","author":"Deodhar","year":"2017","journal-title":"Biotechnol. J"},{"issue":"23","key":"10.1016\/B978-0-12-813669-0.00010-5_bib17","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1016\/j.apsusc.2009.07.037","article-title":"Tuning the morphology of mesoporous silica by using various template combinations","volume":"255","author":"Du","year":"2009","journal-title":"Appl. Surf. Sci."},{"issue":"12","key":"10.1016\/B978-0-12-813669-0.00010-5_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(03)01280-4","article-title":"Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials","volume":"4","author":"Eigentler","year":"2003","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/B978-0-12-813669-0.00010-5_bib19","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1200\/JCO.1998.16.5.1743","volume":"16","author":"Falkson","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib20","doi-asserted-by":"crossref","first-page":"e1421","DOI":"10.1002\/wnan.1421","article-title":"Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?","volume":"9","author":"Fontana","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/inorganics4020009","article-title":"Synthesis and textural characterization of mesoporous and meso-\/macroporous silica monoliths obtained by spinodal decomposition","volume":"4","author":"Galarneau","year":"2016","journal-title":"Inorganics"},{"issue":"47","key":"10.1016\/B978-0-12-813669-0.00010-5_bib22","doi-asserted-by":"crossref","first-page":"19573","DOI":"10.1039\/C6NR07062K","article-title":"99m Tc-conjugated manganese-based mesoporous silica nanoparticles for SPECT, pH-responsive MRI and anti-cancer drug delivery","volume":"8","author":"Gao","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pdpdt.2016.10.002","article-title":"The synergistic effect of photodynamic therapy and photothermal therapy in the presence of gold-gold sulfide nanoshells conjugated Indocyanine green on HeLa cells","volume":"17","author":"Ghorbani","year":"2017","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1387-1811(98)00255-8","article-title":"Novel pathways for the preparation of mesoporous MCM-41 materials: control of porosity and morphology","volume":"27","author":"Gr\u00fcn","year":"1999","journal-title":"Micropor. Mesopor. Mater."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2003.11.006","article-title":"Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts","volume":"95","author":"Gupta","year":"2004","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/B978-0-12-813669-0.00010-5_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/10717540601098823","article-title":"Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery","volume":"14","author":"Heikkil\u00e4","year":"2007","journal-title":"Drug Deliv."},{"issue":"8","key":"10.1016\/B978-0-12-813669-0.00010-5_bib27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/138920009790274540","article-title":"Therapeutic nanoparticles to combat cancer drug resistance","volume":"10","author":"Hu","year":"2009","journal-title":"Curr. Drug Metab."},{"issue":"3","key":"10.1016\/B978-0-12-813669-0.00010-5_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.biomaterials.2009.09.060","article-title":"The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function","volume":"31","author":"Huang","year":"2010","journal-title":"Biomaterials"},{"issue":"24","key":"10.1016\/B978-0-12-813669-0.00010-5_bib29","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/j.biomaterials.2010.04.055","article-title":"The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species","volume":"31","author":"Huang","year":"2010","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/B978-0-12-813669-0.00010-5_bib30","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1021\/nn200365a","article-title":"The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo","volume":"5","author":"Huang","year":"2011","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/B978-0-12-813669-0.00010-5_bib31","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.3390\/ma6094139","article-title":"SBA-15 mesoporous silica as catalytic support for hydrodesulfurization catalysts\u2014review","volume":"6","author":"Huirache-Acu\u00f1a","year":"2013","journal-title":"Materials"},{"issue":"10","key":"10.1016\/B978-0-12-813669-0.00010-5_bib32","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/nm.2933","article-title":"In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers","volume":"18","author":"Idris","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcis.2011.07.063","article-title":"Surface chemical modification to control molecular interactions with porous silicon","volume":"363","author":"Jarvis","year":"2011","journal-title":"J. Colloid Interf. Sci."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.3071","article-title":"Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy","volume":"33","author":"Kim","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/B978-0-12-813669-0.00010-5_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1586\/erm.13.15","article-title":"Nanotheranostics for personalized medicine","volume":"13","author":"Kim","year":"2013","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2011.05.021","article-title":"Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole","volume":"414","author":"Kinnari","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/B978-0-12-813669-0.00010-5_bib38","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1039\/c3cs60016e","article-title":"The discovery of mesoporous molecular sieves from the twenty year perspective","volume":"42","author":"Kresge","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/cm981006e","article-title":"Relations between pore structure parameters and their implications for characterization of MCM-41 using gas adsorption and X-ray diffraction","volume":"11","author":"Kruk","year":"1999","journal-title":"Chem. Mater."},{"issue":"12","key":"10.1016\/B978-0-12-813669-0.00010-5_bib40","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/tx700326b","article-title":"Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles","volume":"20","author":"Laaksonen","year":"2007","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10973-005-0666-x","article-title":"Use of thermoanalytical methods in quantification of drug load in mesoporous silicon microparticles","volume":"80","author":"Lehto","year":"2005","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3181\/00379727-110-27470","article-title":"Silicon in biological material. II. Variations in silicon contents in tissues of rat at different ages","volume":"110","author":"Leslie","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"3","key":"10.1016\/B978-0-12-813669-0.00010-5_bib43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nano.2014.11.006","article-title":"Recent advances in targeted nanoparticles drug delivery to melanoma","volume":"11","author":"Li","year":"2015","journal-title":"Nanomedicine (NY, USA)."},{"issue":"9","key":"10.1016\/B978-0-12-813669-0.00010-5_bib44","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/cm703375p","article-title":"Growth and morphology of mesoporous SBA-15 particles","volume":"20","author":"Linton","year":"2008","journal-title":"Chem. Mater."},{"issue":"6","key":"10.1016\/B978-0-12-813669-0.00010-5_bib45","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.biomaterials.2010.10.035","article-title":"Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice","volume":"32","author":"Liu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib46","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2147\/IJN.S75098","article-title":"Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells","volume":"10","author":"Liu","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"15","key":"10.1016\/B978-0-12-813669-0.00010-5_bib47","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/j.biomaterials.2009.02.008","article-title":"The biocompatibility of porous silicon in tissues of the eye","volume":"30","author":"Low","year":"2009","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/B978-0-12-813669-0.00010-5_bib48","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/smll.200900005","article-title":"Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles","volume":"5","author":"Lu","year":"2009","journal-title":"Small"},{"issue":"8","key":"10.1016\/B978-0-12-813669-0.00010-5_bib49","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/smll.200700005","article-title":"Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs","volume":"3","author":"Lu","year":"2007","journal-title":"Small"},{"issue":"16","key":"10.1016\/B978-0-12-813669-0.00010-5_bib50","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/smll.201000538","article-title":"Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals","volume":"6","author":"Lu","year":"2010","journal-title":"Small"},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib51","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.2147\/DDDT.S116286","article-title":"Loading cisplatin onto 6-mercaptopurine covalently modified MSNS: a nanomedicine strategy to improve the outcome of cisplatin therapy","volume":"10","author":"Lv","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"46","key":"10.1016\/B978-0-12-813669-0.00010-5_bib52","doi-asserted-by":"crossref","first-page":"15593","DOI":"10.1002\/chem.201302736","article-title":"Integrated hollow mesoporous silica nanoparticles for target drug\/siRNA co-delivery","volume":"19","author":"Ma","year":"2013","journal-title":"Chem. Eur. J."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3109\/10837450.2013.823989","article-title":"Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug","volume":"19","author":"Macedo","year":"2014","journal-title":"Pharm. Dev. Technol."},{"issue":"10","key":"10.1016\/B978-0-12-813669-0.00010-5_bib54","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1246\/cl.2008.1040","article-title":"Nanosized polymer particle-facilitated preparation of mesoporous silica particles using a spray method","volume":"37","author":"Nandiyanto","year":"2008","journal-title":"Chem. Lett."},{"issue":"3","key":"10.1016\/B978-0-12-813669-0.00010-5_bib55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.micromeso.2008.12.019","article-title":"Synthesis of spherical mesoporous silica nanoparticles with nanometer-size controllable pores and outer diameters","volume":"120","author":"Nandiyanto","year":"2009","journal-title":"Micropor. Mesopor. Mater."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/02652039109373959","article-title":"Silicon in foods and diets","volume":"8","author":"Pennington","year":"1991","journal-title":"Food Addit. Contam."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2016.12.021","article-title":"Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation","volume":"167","author":"Rizzi","year":"2017","journal-title":"J. Photochem. Photobiol. B"},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/nnm.11.166","article-title":"Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage","volume":"7","author":"Rosenholm","year":"2012","journal-title":"Nanomed. (Lond.)"},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib59","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/nn1029229","article-title":"Smart drug delivery through DNA\/magnetic nanoparticle gates","volume":"5","author":"Ruiz-Hernandez","year":"2011","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib60","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jconrel.2005.08.017","article-title":"Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs","volume":"108","author":"Salonen","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejpb.2014.11.022","article-title":"Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies","volume":"89","author":"Sapino","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/B978-0-12-813669-0.00010-5_bib62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/157016311796799026","article-title":"Silica materials in drug delivery applications","volume":"8","author":"Simovic","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0927-7757(01)00612-4","article-title":"The use of nitrogen adsorption for the characterisation of porous materials","volume":"187","author":"Sing","year":"2001","journal-title":"Colloids Surf. Physicochem. Eng. Aspects"},{"issue":"46","key":"10.1016\/B978-0-12-813669-0.00010-5_bib64","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/ja0645943","article-title":"Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells","volume":"128","author":"Slowing","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/smll.200800926","article-title":"Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells","volume":"5","author":"Slowing","year":"2009","journal-title":"Small"},{"issue":"21","key":"10.1016\/B978-0-12-813669-0.00010-5_bib66","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1016\/j.biomaterials.2010.03.048","article-title":"Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles","volume":"31","author":"Souris","year":"2010","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/B978-0-12-813669-0.00010-5_bib67","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1002\/chem.201403551","article-title":"Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups","volume":"20","author":"Tan","year":"2014","journal-title":"Chem. Eur. J."},{"issue":"12","key":"10.1016\/B978-0-12-813669-0.00010-5_bib68","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/B978-0-12-813669-0.00010-5_bib69","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/ar3000986","article-title":"Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility","volume":"46","author":"Tarn","year":"2013","journal-title":"Acc. Chem. Res."},{"issue":"9","key":"10.1016\/B978-0-12-813669-0.00010-5_bib70","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1021\/ar600032u","article-title":"Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol\u2013gel process and applications in controlled release","volume":"40","author":"Trewyn","year":"2007","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/smll.200700457","article-title":"High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe","volume":"4","author":"Tsai","year":"2008","journal-title":"Small"},{"issue":"5","key":"10.1016\/B978-0-12-813669-0.00010-5_bib72","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/chem.201504629","article-title":"Targeting innate immunity with dsRNA\u2014conjugated mesoporous silica nanoparticles promotes antitumor effects on breast cancer cells","volume":"22","author":"Ultimo","year":"2016","journal-title":"Chem. Eur. J."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.nano.2015.11.013","article-title":"Aspect ratios of gold nanoshell capsules mediated melanoma ablation by synergistic photothermal therapy and chemotherapy","volume":"12","author":"Wang","year":"2016","journal-title":"Nanomed. (NY, USA)"},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1387-1811(02)00531-0","article-title":"Ordered mesoporous materials for drug delivery","volume":"117","author":"Wang","year":"2009","journal-title":"Micropor. Mesopor. Mater."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib75","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.micromeso.2011.04.033","article-title":"Novel synthesis of Fe-containing mesoporous carbons and their release of ibuprofen","volume":"145","author":"Wang","year":"2011","journal-title":"Micropor. Mesopor. Mater."},{"issue":"4","key":"10.1016\/B978-0-12-813669-0.00010-5_bib76","first-page":"1337","article-title":"Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib77","first-page":"5807","article-title":"Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica","volume":"7","author":"Wang","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"44","key":"10.1016\/B978-0-12-813669-0.00010-5_bib78","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1002\/smll.201501056","article-title":"Cancer-cell-specific nuclear-targeted drug delivery by dual-ligand-modified mesoporous silica nanoparticles","volume":"11","author":"Xiong","year":"2015","journal-title":"Small"},{"issue":"1","key":"10.1016\/B978-0-12-813669-0.00010-5_bib79","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2012.09.008","article-title":"Mesoporous systems for poorly soluble drugs","volume":"453","author":"Xu","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/B978-0-12-813669-0.00010-5_bib80","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1039\/c2cs15308d","article-title":"Functionalized mesoporous silica materials for controlled drug delivery","volume":"41","author":"Yang","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/B978-0-12-813669-0.00010-5_bib81","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/cm035011g","article-title":"Morphology development of mesoporous materials: a colloidal phase separation mechanism","volume":"16","author":"Yu","year":"2004","journal-title":"Chem. Mater."},{"issue":"12","key":"10.1016\/B978-0-12-813669-0.00010-5_bib82","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","article-title":"Cancer stem cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1021\/cm9911363","article-title":"Morphological control of highly ordered mesoporous silica SBA-15","volume":"12","author":"Zhao","year":"2000","journal-title":"Chem. Mater."},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib84","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jnoncrysol.2011.09.020","article-title":"Fabrication of mesoporous hydroxycarbonate apatite for oral delivery of poorly water soluble drug carvedilol","volume":"358","author":"Zhao","year":"2012","journal-title":"J. Non-Cryst. Solids"},{"issue":"2","key":"10.1016\/B978-0-12-813669-0.00010-5_bib85","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/nn103077k","article-title":"Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects","volume":"5","author":"Zhao","year":"2011","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/B978-0-12-813669-0.00010-5_bib86","first-page":"1557","article-title":"Antitumor activity of monomethoxy poly(ethylene glycol)-poly (epsilon-caprolactone) micelle-encapsulated doxorubicin against mouse melanoma","volume":"25","author":"Zheng","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/B978-0-12-813669-0.00010-5_bib87","series-title":"Nanobiomaterials in Galenic Formulations and Cosmetics","first-page":"231","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel carriers for cosmetic ingredients","author":"Zieli\u0144ska","year":"2016"}],"container-title":["Design of Nanostructures for Theranostics Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136690000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128136690000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T06:14:33Z","timestamp":1570860873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128136690000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128136690"],"references-count":87,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-813669-0.00010-5","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}